Loading...
BioDlink International Company Limited
1875.HK•HKSE
Healthcare
Biotechnology
HK$5.07
HK$-0.08(-1.55%)
Hong Kong Market is Open • 11:53BioDlink International Company Limited (1875.HK) AI-Powered Stock Analysis
See how BioDlink International Company Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBioDlink International Company Limited (1875.HK) Stock Overall Grade
BioDlink International Company Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to BioDlink International Company Limited's overall stock rating.
Forecast
C+Score
55/100Financial Growth
A+Score
100/100Fundamental Growth
CScore
43/100Key Ratios
C+Score
54/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100BioDlink International Company Limited (1875.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (43/100, C) highlight its stability, while Key Ratios (54/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each BioDlink International Company Limited stock grade, including financials, comparisons, and forecasts.